Das Medizinportal     Aktuelles für medizinische Fachkreise
Menü

Das Medizinportal     Aktuelles für medizinische Fachkreise

Literatur:

Die Behandlung der koronaren Herzkrankheit aus der Sicht der Herzchirurgie
Autor: Christof Schmid, Regensburg

  1. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35:2541-2619.
  2. Hannan EL, Racz MJ, Gold J, Cozzens K, Stamato NJ, Powell T, et al. Adherence of catheterization laboratory cardiologists to American College of Cardiology/American Heart Association guidelines for percutaneous coronary interventions and coronary artery bypass graft surgery: what happens in actual practice? Circulation. 2010;121:267-275.
  3. Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012;367:2375-2384.
  4. Kappetein AP, Head SJ, Morice MC, Banning AP, Serruys PW, Mohr FW, et al. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur J Cardiothorac Surg. 2013;43:1006-1013.
  5. Racz MJ, Hannan EL, Isom OW, Subramanian VA, Jones RH, Gold JP, et al. A comparison of short- and long-term outcomes after off-pump and on-pump coronary artery bypass graft surgery with sternotomy. J Am Coll Cardiol. 2004;43:557-564.
  6. Hannan EL, Wu C, Smith CR, Higgins RS, Carlson RE, Culliford AT, et al. Off-pump versus on-pump coronary artery bypass graft surgery: differences in short-term outcomes and in long-term mortality and need for subsequent revascularization. Circulation. 2007;116:1145-1152.
  7. Aldea GS, Bakaeen FG, Pal J, Fremes S, Head SJ, Sabik J, et al. The Society of Thoracic Surgeons Clinical Practice Guidelines on Arterial Conduits for Coronary Artery Bypass Grafting. Ann Thorac Surg. 2016;101:801-809.
  8. Beckmann A, Funkat AK, Lewandowski J, Frie M, Ernst M, Hekmat K, et al. German Heart Surgery Report 2015: The Annual Updated Registry of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg. 2016;64:462-474.
  9. Taggart DP, Altman DG, Gray AM, Lees B, Gerry S, Benedetto U, et al. Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery Grafts. N Engl J Med. 2016;375:2540-2549.

Zusammenarbeit zwischen Kardiochirurgen und Kardiologen im Bereich der Rhythmusstörungen/Rhythmustherapie aus kardiochirurgischer Sicht
Autor: Nicolas Doll, Stuttgart

  1. Cox JL Boineau JP, Schuessler RB, Katr KM, Ferguson TB Jr, Cain ME et al.: Electrophysiologic basis, surgical development, and clinical results of the Maze procedure for atrial flutter and atrial fibrillation. Adv Cad Surg 1995; 6: 1-67.
  2. Cox JL, Ad N, Palazzo T: Impact of the Maze procedure on the stroke rate in patients with atrial fibrillation. J Thorac Cardiovasc Surg 1999; 118: 833-40.
  3. Hindricks G, Kottkamp H, Hammel D et al.: Radiofrequency ablation of atrial fibrillation: Early clinical experience with a catheter-guided intraoperative approach. Eur. Heart. J. 18, 135 (1997). 
  4. Seeburger J, Borger MA, Falk V, Kuntze T, Czesla M, Walther T, Doll N, Mohr FW: Minimal invasive mitral valve repair for mitral regurgitation: results of 1339 consecutive patients. Eur J Cardiothorac Surg. 2008; 34 (4): 760-5.
  5. Hindricks G, Mohr FW, Autschbach R et al: Antiarrhythmic surgery for treatment of atrial fibrillation: new concepts. Thorac. Cardiovasc. Surg. 47(3), 365-369 (1999).
  6. Mohr FW, Fabricius A, Falk V et al: Curative treatment of atrial fibrillation: Acute- and mid-term results of intraoperative radiofrequency ablation of atrial fibrillation. J. Thorac. Cardiovasc. Surg. 123, 919-927 (2002).
  7. Mohr FW, Fabricius A, Falk V, Autschbach R, Doll N, von Oppell U, Diegeler A, Kottkamp H, Hindricks G: Curative treatment of atrial fibrillation with intraoperative radiofrequency ablation: short-term and midterm results. J Thorac Cardiovasc Surg 2002; 123:919-27.
  8. Doll N, Borger M, Fabricius A, Stephan S, Gummert J, Hauss J, Kottkamp H, Hindricks G, Mohr FW: Esophageal perforation during left atrial radiofrequency ablation: Is the risk to high? J Thorac Cardiovasc Surg 2003 Apr; 125(4): 836-42.
  9. Whitlock R et al. Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III. Ann Cardiothorac Surg. 2014 Jan; 3(1): 45-54.
  10. Aupperle H, Doll N, Walther T, Kornherr P, Ullmann C, Schoon H-A, Mohr FW: Ablation of atrial fibrillation and esophageal injury: Effects of energy source and ablation technique. J Thorac Cardiovasc Surg. 2005 Dec 130: 1549-54.
  11. Doll N, Aupperle H, Borger M, Czesla, Mohr F.W.: Experimentelle Evaluierung verschiedener Energiequellen und Applikationsverfahren zur chirurgischen Therapie des Vorhofflimmerns. Herzschr Elektrophys 2007; 18(2): 83-91.
  12. Doll N, Fabricius AM, Meyer R, Walther T, Rastan A, Mohr FW: Surgical treatment of atrial fibrillation with argon-based cryotechnology. Future Cardiol.2005; 1(3): 381-91.
  13. Doll N, Meyer R, Walther T, Mohr FW: A new cryoprobe for intraoperative ablation of atrial fibrillation. Ann Thorac Surg 2004; 77(4): 1460-2.
  14. Doll N, Kiaii B, Bucerius J, Kornherr P, Krakor R, Walther T, Gummert JF, Fabricius AM, Mohr FW: Intraoperative left atrial ablation (for atrial fibrillation) using a new Argon cryo catheter. Early clinical experience. Ann Thorac Surg 2003; 76: 1711-5.
  15. Willems S, Doll N, Steven D, Czesla M, Hoffmann B, Weimar T: New strategies for interventional and surgical therapy of atrial fibrillation. DMW - Deutsche Medizinische Wochenschrift 09/2012; 137(39):1916-24.
  16. Weimar T, Vosseler M, Czesla M, Boscheinen M, Hemmer WB, Doll N: Approaching a Paradigm Shift: Endoscopic Ablation of Lone Atrial Fibrillation on the Beating Heart. Ann Thorac Surg 2012; 94(6): 1886-92.
  17. EHRA Scientific Committee Task Force: Bulent Gorenek (chair)et al. European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS) 2017 19, 190–225.
  18. Vinay Badhwar et al. The Society of Thoracic Surgeons Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation 2017. Ann Thorac Surg 2017;103: 329–41.

Valvuläre Erkrankungen – Die Bedeutung des „Heart Teams“ aus kardiologischer und herzchirurgischer Sicht
Autoren: Lars Oliver Conzelmann, Bernd-Dieter Gonska, Uwe Mehlhorn , AlexanderWürth, Karlsruhe

  1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006; 368: 1005-11.
  2. Afilalo J, Eisenberg MJ, Morin JF, Bergman H, Monette J, Noiseux N, Perrault LP, Alexander KP, Langlois Y, Dendukuri N, Chamoun P, Kasparian G, Robichaud S, Gharacholou SM, Boivin JF. Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. J Am Coll Cardiol. 2010; 56: 1668-76. 
  3. Austin WO, Adams FH, Holve L. The cardiac team; an introduction to a sympostium on congenital heart disease. Calif Med. 1957; 86: 161.
  4. Serruys PW. The Heart Team – perpetually mutating. EuroIntervention 2016; 12: 693.
  5. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Ståhle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW; SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009; 360: 961-72.
  6. Holmes D.R. Jr., Mohr F, Hamm CW, Mack MJ. Venn diagrams in cardiovascular disease: the Heart Team concept. Eur Heart J. 2014; 35: 66-68.
  7. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI), Kolh P, Wijns W, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D. Guidelines on myocardial revascularisation. Eur J Cardiothorac Surg 2010; 38: S1–52.
  8. Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, Cigarroa JE, Disesa VJ, Hiratzka LF, Hutter AM Jr, Jessen ME, Keeley EC, Lahey SJ, Lange RA, London MJ, Mack MJ, Patel MR, Puskas JD, Sabik JF, Selnes O, Shahian DM, Trost JC, Winniford MD. Circulation 2011; 124: 2610–42.
  9. Vahanian A, Alfieri O, Andreotti F et al; Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). Guideline on the management of valvular heart disease (version 2012). Eur Heart J 2012; 33: 2451–2496.
  10. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, Jneid H, Mack MJ, McLeod CJ, O'Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A. Circulation 2017; 135: e1159-1195.
  11. Kuck KH, Eggebrecht H, Elsässer A et al. Qualitätskriterien zur Durchführung der transvaskulären Aortenklappenimplantation (TAVI). Kardiologe 2016; 10: 282.
  12. Nickenig G, Mohr FW, Kelm M, Kuck K-H, Boekstegers P, Hausleiter J, Schillinger W, Brachmann J, Lange R, Reichenspurner H. Konsensus der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung – und der Deutschen Gesellschaft für Thorax-, Herz- und Gefäßchirurgie zur Behandlung der Mitralklappeninsuffizienz. Kardiologe 2013; 7: 76–90.
  13. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL; Document Reviewers, Erol Ç, Nihoyannopoulos P, Aboyans V, Agewall S, Athanassopoulos G, Aytekin S, Benzer W, Bueno H, Broekhuizen L, Carerj S, Cosyns B, De Backer J, De Bonis M, Dimopoulos K, Donal E, Drexel H, Flachskampf FA, Hall R, Halvorsen S, Hoen B, Kirchhof P, Lainscak M, Leite-Moreira AF, Lip GY, Mestres CA, Piepoli MF, Punjabi PP, Rapezzi C, Rosenhek R, Siebens K, Tamargo J, Walker DM. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015; 36: 3075–3123.
  14. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ, Barsic B, Lockhart PB, Gewitz MH, Levison ME, Bolger AF, Steckelberg JM, Baltimore RS, Fink AM, O'Gara P, Taubert KA; American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation. 2015; 132: 1435-86.
  15. Figulla HR, Cremer J, Walther T et al. Positionspapier zur kathetergeführten Aortenklappenintervention. Kardiologe 2009; 3: 199–206.
  16. Kappetein AP, Head SJ, Généreux P et al.; Valve Academic Research Consortium-2. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg. 2013; 145: 6-23.
  17. Markewitz A, Franke A (2010) Herzchirurgische Intensivmedizin. In: Ziemer G, Haverich A (Hrsg) Herzchirurgie. Springer, Berlin Heidelberg New York Tokio, S 135–210.
  18. www.g-ba.de/institution/presse/pressemitteilungen/568/.
  19. Mylotte D, Piazza N. Patient selection for transcatheter or surgical intervention: the Heart Team TRUMPS the STS. EuroIntervention 2016; 12: 1439-40.

Erweiterte Diagnostik zur Förderung der Compliance in der Statintherapie
Autoren: Carolin Claus und Uwe May, Idstein

  1.  Boehm, M., Laufs, U., Hamm, C. Positionspapier zur Statintherapie, Clin. Res. Cardiol. Suppl. 2007; 2: 8-15.
  2. Statistisches Bundesamt (2015) Krankheitskosten 2008.
  3. Li, J., Joy, S., Haga, S. Genetically Guided Statin Therapy on Statin Perceptions, Adherence, and Cholesterol Lowering: A Pilot Implementation Study in Primary Care Patients. Journal of Personalized Medicine 2014; 4: 147-162.
  4. Bruckert, E., Hayem, G., Dejager, S. Mild to Moderate Muscular Symptoms with High- Dosage Statin Therapy in Hyperlipidemic Patients - The PRIMO Study. Cardiovascular Drugs and Therapy 2005; 19: 403-414.
  5. Stroes, E., Thompson, P., Corsini, A. Statin- associated muscle symptoms: impact on statin therapy- European Atherosclerosis Society Consensus Panel Statement on Assessment, Etiology and Management. European Heart Journal 2015; 36: 1012-1022.
  6. Fernandez, G., Spatz, E., Jablecki, C. Statin myopathy: A common dilemma not reflected in clinical trials. Cleveland Clinical Journal of Medicine 2011; 78: 393-403.
  7. Volmer, T., Kielhorn, A., Kosten der Non-Compliance. Gesundh. Ökon. Qual. Manag. 4 (1999) 55-61. 
  8. Gräf, M., Die volkswirtschaftlichen Kosten der Non-Compliance: Eine entscheidungsorientierte Analyse. Bayreuth P.C.O.-Verlag 2007. 
  9. Zintzaras, E., Kitsios, Gd., Triposkiadis, F. APOE gene polymorphisms and response to statin therapy. The Pharmacogenomics Journal 2009; 9: 248-257.
  10. Superko, HR., Momary, K., Li, Y. (2011) Statins Personalized. [Online] available from www.researchgate.net/publication/221888915_Statins_Personalized.